KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Non Operating Income: 2012-2025

Historic Non Operating Income for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to -$83.1 million.

  • Sarepta Therapeutics' Non Operating Income fell 682.24% to -$83.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$47.0 million, marking a year-over-year decrease of 293.86%. This contributed to the annual value of $42.7 million for FY2024, which is 116.92% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Non Operating Income of -$83.1 million as of Q2 2025, which was down 926.20% from $10.1 million recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Non Operating Income registered a high of $118.9 million during Q2 2023, and its lowest value of -$374.6 million during Q1 2023.
  • For the 3-year period, Sarepta Therapeutics' Non Operating Income averaged around -$32.5 million, with its median value being $10.1 million (2024).
  • Over the last 5 years, Sarepta Therapeutics' Non Operating Income had its largest YoY gain of 801.22% in 2023, and its largest YoY loss of 2,069.83% in 2023.
  • Sarepta Therapeutics' Non Operating Income (Quarterly) stood at -$118.1 million in 2021, then surged by 104.68% to $5.5 million in 2022, then skyrocketed by 184.89% to $15.7 million in 2023, then tumbled by 36.10% to $10.1 million in 2024, then tumbled by 682.24% to -$83.1 million in 2025.
  • Its Non Operating Income stands at -$83.1 million for Q2 2025, versus $10.1 million for Q4 2024 and $11.8 million for Q3 2024.